Christopher Wright
Director/Board Member at ALKERMES PLC
Net worth: 228 782 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Pops | M | 62 | 33 years | |
| Blair Jackson | M | 51 | 25 years | |
| Shane Cooke | M | 61 | 13 years | |
| David Gaffin | M | 52 | 8 years | |
| Richard Gaynor | M | 74 | 5 years | |
| Emily Alva | F | 49 | 3 years | |
| C. Nichols | M | - | 5 years | |
| Cato Laurencin | M | 65 | 3 years | |
| Andy Wilson | M | 65 | 5 years | |
| Declan O’Connor | M | - | 13 years | |
| Dave Daglio | M | - | 4 years | |
| Brian McKeon | M | 61 | 4 years | |
| Nancy Snyderman | M | 72 | 8 years | |
| Stephen Schiavo | M | - | 6 years | |
| Kanchan Relwani | M | - | 7 years | |
| John Huynh | M | - |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 3 years |
| Spencer Fisk | M | - |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Heather Faulds | F | - | 4 years | |
| Thomas Harvey | M | - | 19 years | |
| Katie Joyce | F | - | - | |
| Anne Giovanoni | F | - | - | |
| Sandy Coombs | F | - | 15 years | |
| Rahul Singhvi | M | 59 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 5 years |
| Peter Norman | M | - | 11 years | |
| Craig Hopkinson | M | 56 | 7 years | |
| Tu Yen Ong | M | 49 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Konstantin Konstantinov | M | 66 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 1 years |
| Francois Nader | M | 67 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 3 years |
| Markus Haeberlein | M | - | - | |
| Juan Andres | M | 59 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Niels Borgstein | M | - | 3 years | |
| Christopher McNulty | M | 47 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 1 years |
| Sondra Smyrnios | F | - | 5 years | |
| David Epstein | M | 62 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 2 years |
| B. Parshall | F | 70 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | 2 years |
| Noubar Afeyan | M | 60 |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | - |
| Michael Landine | M | 70 | 13 years | |
| Samuel Parisi | M | 49 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wendy Dixon | M | 68 | 11 years | |
| Nancy Wysenski | F | 66 | 10 years | |
| David Anstice | M | 75 | 14 years | |
| Iain Brown | M | 55 | 21 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Ireland | 31 | 73.81% |
| United States | 11 | 26.19% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christopher Wright
- Personal Network
